What is NDC 15370-307?

15370-307 is the product NDC for POKONZA potassium chloride (potassium chloride), Potassium chloride 10 meq/15mL liquid, listed with the FDA by Carwin Pharmaceutical Associates, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

POKONZA potassium chloride (Potassium chloride).

Carwin Pharmaceutical Associates, LLC, NDC labeler code 15370. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for POKONZA potassium chloride?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

POKONZA potassium chloride NDC 15370-307

NDC codes

FDA NDC Directory

Product NDC (as listed)15370-307Labeler and product segments. Claims need a package NDC.

Product NDC at billing width15370-0307Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
15370-307-04	1537003070415370030704	118 mL in 1 BOTTLE (15370-307-04)Marketed from Jan 14, 2026
15370-307-08	1537003070815370030708	237 mL in 1 BOTTLE (15370-307-08)Marketed from Jan 14, 2026
15370-307-16	1537003071615370030716	473 mL in 1 BOTTLE (15370-307-16)Marketed from Jan 14, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): POKONZA potassium chloride
Generic name (nonproprietary): potassium chloride
Active ingredients: Potassium chloride — 10 meq/15mL
Dosage form: Liquid
Route: Oral
Labeler: Carwin Pharmaceutical Associates, LLCNDC labeler code 15370
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 206814
Marketing start: Jan 14, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 15370-307_63d621b7-ee4e-4230-be7e-f186ea90fe11SPL ID 63d621b7-ee4e-4230-be7e-f186ea90fe11SPL set ID 2d938cbf-27aa-4f9c-a582-5564d3b72465RxCUI 2734000, 2734004UNII 660YQ98I10UPC 0315370307049
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N415370030704 followed by a unit qualifier and the quantity

Package 15370-0307-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2026.

Indications (excerpt from the label)

POKONZA ® (Potassium Chloride Oral Solution, USP) is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. POKONZA ® (Potassium Chloride Oral Solution, USP) is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 15370-307

What is NDC 15370-307?: 15370-307 is the product NDC for POKONZA potassium chloride (potassium chloride), Potassium chloride 10 meq/15mL liquid, listed with the FDA by Carwin Pharmaceutical Associates, LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: POKONZA potassium chloride (Potassium chloride).
What is the active ingredient?: Potassium chloride.
Who is the labeler?: Carwin Pharmaceutical Associates, LLC, NDC labeler code 15370. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for POKONZA potassium chloride?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 206814

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 206814
Product	Strength	Form · route	Labeler	Product NDC
Potassium Chloride	Potassium chloride 20 meq/15mL	SolutionOral	Genus Lifesciences	64950-320

POKONZA potassium chloride (Potassium chloride) NDC 15370-307